The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $32.16

Today's change0.00 0.00%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $32.16

Today's change0.00 0.00%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc closed at (U.S.)$32.16.

This security is unchanged over the last five days and the last 52 weeks. This security has underperformed the S&P 500 by 21.90% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $32.16
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-0.99%
  • Volume0
  • Average volume (10-day)24,136,818
  • Average volume (1-month)22,767,411
  • Average volume (3-month)23,900,296
  • 52-week range(U.S.) $29.83 to (U.S.) $37.39
  • Beta1.00
  • Trailing P/E26.96×
  • P/E 1 year forward12.60×
  • Forward PEG2.23×
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield3.98%
  • Trailing EPS(U.S.) $1.19
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.06%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 02, 201704/02/2017Dec 31, 201612/31/2016Oct 02, 201610/02/2016Jul 03, 201607/03/2016
Revenue12,77913,62813,04513,147
Total other revenue--------
Total revenue12,77913,62813,04513,147
Gross profit10,30610,4149,9639,973
Total cost of revenue2,4733,2143,0823,174
Total operating expense8,55212,70711,33510,547
Selling / general / administrative3,3084,4233,5593,471
Research & development1,7082,5121,8811,748
Depreciation / amortization1,1861,122968961
Interest expense (income), net operating--------
Unusual expense (income)1961,4942,1181,453
Other operating expenses, total-319-58-273-260
Operating income4,2279211,7102,600
Interest income (expense), net non-operating-325-312-309-308
Gain (loss) on sale of assets95904731
Other--------
Income before tax3,9517761,6042,410
Income after tax3,1308471,3202,035
Income tax, total821-71284375
Net income3,1218581,3202,020
Total adjustments to net income--1-1-1
Net income before extra. items3,1218411,3202,019
Minority interest-9-60-16
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,1218421,3192,018
Inc. avail. to common incl. extra. items3,1218591,3192,019
Diluted net income3,1218591,3192,019
Dilution adjustment0--00
Diluted weighted average shares6,0926,1446,1386,137
Diluted EPS excluding extraordinary itemsvalue per share0.510.140.210.33
Dividends per sharevalue per share0.320.300.300.30
Diluted normalized EPSvalue per share0.520.360.540.55